Boston Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
MG
Boston Advisors's EXEL Position: Q3 2019 in Review
Boston Advisors increased its Exelixis (EXEL) stake by 8.9% in Q3 2019, buying an estimated $171K and bringing the position to 103,156 shares worth $1.82M. The position accounts for 0.1% of the portfolio, ranked #265.
Boston Advisors first reported a position in EXEL in Q4 2018 and has held it in 4 quarters since. The position peaked at $2.67M in Q1 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.
- Boston Advisors held 103,156 shares of Exelixis worth $1.82M as of Q3 2019.
- Boston Advisors bought 8,428 Exelixis shares in Q3 2019, an estimated $171K.
- Exelixis made up 0.1% of Boston Advisors's portfolio in Q3 2019, its #265 holding.
- Boston Advisors first reported a position in Exelixis in Q4 2018 and has held it in 4 quarters since.
- Boston Advisors's Exelixis position peaked at $2.67M in Q1 2019.
- 339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.
Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.